The FDA will utilize Rosetta Biosoftware’s Syllego™ system to manage and analyze genotyping data used in genome-wide association (GWA) studies. Organizations are now beginning to submit GWA study results to the FDA through its Voluntary eXploratory Data Submission program.

This site uses Akismet to reduce spam. Learn how your comment data is processed.